Study: Easing buprenorphine access did not increase related overdoses
The share of U.S. overdose deaths involving buprenorphine did not increase after federal agencies allowed clinicians to prescribe the opioid use disorder treatment remotely, among other flexibilities during the COVID-19 public health emergency, according to a reported today in JAMA Network Open.
鈥淩esearch has shown beyond a doubt that medications for opioid use disorder are overwhelmingly beneficial and can be lifesaving, yet they continue to be vastly underused,鈥 said senior author Nora Volkow, M.D., director of the National Institute on Drug Abuse. 鈥淓xpanding more equitable access to these medications for people with substance use disorders is a critical part of our nation鈥檚 response to the overdose crisis.鈥
Related News Articles
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in鈥
Headline
The Department of Health and Human Services March 18 announced that it renewed the public health emergency for the nation鈥檚 opioid crisis an additional 90 days鈥
Headline
The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid鈥
Headline
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding鈥
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to鈥
Headline
The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention as part of its National鈥